Liver Capsule: FXR agonists against liver disease
Claudia D. Fuchs, Peter Schwabl, Thomas Reiberger, Michael Trauner – 16 September 2016
Claudia D. Fuchs, Peter Schwabl, Thomas Reiberger, Michael Trauner – 16 September 2016
Pieter Borger, Pierre‐Alain Clavien – 15 September 2016
Petra Hirsova, Samar H. Ibrahim, Vikas K. Verma, Leslie A. Morton, Vijay H. Shah, Nicholas F. LaRusso, Gregory J. Gores, Harmeet Malhi – 15 September 2016 – Extracellular vesicles (EVs) are nanometer‐sized, membrane‐bound vesicles released by cells into the extracellular milieu. EVs are now recognized to play a critical role in cell‐to‐cell communication. EVs contain important cargo in the form of proteins, lipids, and nucleic acids and serve as vectors for delivering this cargo from donor to acceptor or target cell.
Romina Fiorotto, Ambra Villani, Antonis Kourtidis, Roberto Scirpo, Mariangela Amenduni, Peter J. Geibel, Massimiliano Cadamuro, Carlo Spirli, Panos Z. Anastasiadis, Mario Strazzabosco – 15 September 2016 – In the liver, the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) regulates bile secretion and other functions at the apical membrane of biliary epithelial cells (i.e., cholangiocytes). CF‐related liver disease is a major cause of death in patients with CF.
Paul Kaminsky, Joshua Preiss, Eizaburo Sasatomi, David A. Gerber – 15 September 2016
Anthony Brown, John S. Halliday, Leo Swadling, Richie G. Madden, Richard Bendall, Jeremy G. Hunter, James Maggs, Peter Simmonds, Donald B. Smith, Louisa Vine, Cara McLaughlin, Jane Collier, David Bonsall, Katie Jeffery, Susanna Dunachie, Paul Klenerman, Jacques Izopet, Nassim Kamar, Harry R. Dalton, Eleanor Barnes – 15 September 2016 – The interplay between host antiviral immunity and immunopathology during hepatitis E virus (HEV) infection determines important clinical outcomes.
Jeffrey H. Albrecht – 15 September 2016
Hao Zhou, Minjia Yu, Junjie Zhao, Bradley N. Martin, Sanjoy Roychowdhury, Megan R. McMullen, Emily Wang, Paul L. Fox, Sho Yamasaki, Laura E. Nagy, Xiaoxia Li – 15 September 2016 – Lipopolysaccharide (LPS)‐mediated activation of Toll‐like receptors (TLRs) in hepatic macrophages and injury to hepatocytes are major contributors to the pathogenesis of alcoholic liver disease. However, the mechanisms by which TLR‐dependent inflammatory responses and alcohol‐induced hepatocellular damage coordinately lead to alcoholic liver disease are not completely understood.
Mateus T. Guerra – 15 September 2016
Paul Kaminsky, Joshua Preiss, Eizaburo Sasatomi, David A. Gerber – 15 September 2016